Largest Biotechnology companies in Switzerland by Market Capitalization

This ranking features the largest 22 Biotechnology companies in Switzerland ranked by Market Capitalization, totaling a Market Capitalization of USD 606.02 B, for July 07, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Biotechnology company in Switzerland has the highest Market Capitalization ?

The Biotechnology company in Switzerland with the highest Market Capitalization is Roche Holding AG (Swiss Stock Exchange: RO.SW) at USD 260.13 B.

Which Biotechnology company in Switzerland has the lowest Market Capitalization ?

The Biotechnology company in Switzerland with the lowest Market Capitalization is Evolva Holding SA (Swiss Stock Exchange: EVE.SW) at USD 10.25 M.

What are the top 10 Biotechnology companies in Switzerland by Market Capitalization ?

The top 10 Biotechnology companies in Switzerland by Market Capitalization are Roche Holding AG, Novartis AG, Lonza Group AG, Sandoz Group AG, Bachem Holding AG, Siegfried Holding AG, CRISPR Therapeutics AG, MoonLake Immunotherapeutics, Tecan Group AG and BB Biotech AG.

What are the bottom 10 Biotechnology companies in Switzerland by Market Capitalization ?

The bottom 10 Biotechnology companies in Switzerland by Market Capitalization are Evolva Holding SA, NLS Pharmaceutics AG, Molecular Partners AG, Santhera Pharmaceuticals Holding AG, AC Immune SA, ADC Therapeutics SA, Idorsia Ltd, medmix AG, Basilea Pharmaceutica AG and PolyPeptide Group AG.